Syngenta Group announced its financial results for the first quarter of 2025, reporting sales of $7.3 billion, a slight decrease of 1% compared to the same period last year. However, at constant exchange rates (CER), sales increased by 3%.
The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) rose significantly by 18% to $1.4 billion, marking a 26% increase at CER. The EBITDA margin improved to 19.9%, up by 3.2 percentage points from the previous year.
The growth in EBITDA was primarily driven by a robust performance in the Crop Protection segment, which saw sales increase by 5% to $3.4 billion (11% at CER). This growth was attributed to the end of channel destocking, particularly in the U.S., and strong demand for new crop protection technologies, including ADEPIDYN®, PLINAZOLIN®, and TYMIRIUM®. Sales in North America and China grew by 20% and 12%, respectively.
ADAMA, a Syngenta Group company, reported a 5% decrease in sales to $1 billion (3% at CER), reflecting a strategic focus on higher-margin products and the phasing out of lower-margin offerings.
The Seeds business recorded sales of $1.4 billion, a 2% decrease in USD terms but a 1% increase at CER. Notably, seed sales in China grew by 18%, and the Vegetables and Flowers segment saw a 4% increase, offsetting declines in U.S. field crop sales.
Syngenta Group China experienced a 6% decline in sales to $2.5 billion (5% at CER), largely due to the strategic reduction of low-margin businesses. Despite this, the Seeds and Crop Protection divisions within China achieved strong growth.
The company attributed its improved EBITDA margin to lower raw material costs, ongoing productivity initiatives, and a more favorable business mix. Syngenta Group also highlighted sustained investments in research and development to drive innovation and support long-term sustainable growth.
